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ABSTRACT OF DISSERTATION 
EXECUTIVE DEFICITS IN AMYOTROPHIC LATERAL SCLEROSIS: EXAMINING THE 
CONSEQUENCES OF SELF-REGULATORY IMPAIRMENT ON QUALITY OF LIFE 
 
 Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease that attacks 
the motor system and contributes to a range of cognitive and behavioral impairments (e.g., 
behavioral and emotional disinhibition, planning and problem solving difficulties, impulsivity, 
attention, and personality change).  This executive dysfunction may contribute to self-
regulatory impairment across several domains, including cognitive skills, thought processes, 
emotion regulation, interpersonal skills, and physiology, that may be crucial to the quality of 
life (QOL), or well being, of patients and their caregivers.  Given the relentless course and 
prognosis of ALS, palliative treatments for ALS should target the full range of self-regulatory 
deficits.  Thirty-seven patient-caregiver pairs completed questionnaires regarding the patients’ 
ability to regulate emotions, social behavior, and thought patterns.  Patients also completed 
neuropsychological measures of executive functions and provided measures of glycosylated 
hemoglobin (A1c) and heart rate variability (HRV).   Results suggest that SR and EF deficits 
exist on a continuum in ALS, such that some patients evidence adequate or superior ability to 
self-regulate while others evidence deficits.  Patient- caregiver agreement about patients’ self-
regulatory capacity across domains was generally weak to moderate.  Patients perceived 
themselves to have less capacity for global regulation than caregivers perceived them to have, 
patients perceived less dyadic cohesion than caregivers, and patients perceived themselves to 
ruminate more than caregivers indicated.  Overall, caregivers tended to perceive a more 
pervasive pattern of deficits compared to patients.  Additionally, measures of SR and EF were 
not strongly inter-correlated in general, challenging the idea that SR in different domains 
depends on a common resource. Accordingly, correlations among measures of theoretically 
similar constructs (i.e., EF and SR) were small to moderate in magnitude and non-significant.  
With regard to physiological functioning, when patients had better regulated glucose (A1c), 
patients and caregivers perceived better global regulation.  A similar pattern emerged with 
patient ratings, with higher baseline HRV linked to less emotional lability.  Last, mixed results 
were obtained when predicting patient and caregiver QOL.  Less rumination, less dyadic 
cohesion and more social anxiety were associated with higher QOL for patients.  Caregivers’ 
QOL was not significantly related to their perceptions of patients’ self-regulatory capacity in 
any area.  
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Chapter One 
Introduction 
Amyotrophic Lateral Sclerosis (ALS) is a progressive and invariably fatal 
neurodegenerative disease with few options for treatment and no cure.  Most people with ALS 
die within 5 years of the onset of a host of motor symptoms including muscle atrophy and 
cramps, spasticity, fasciculations, progressive motor weakness, and eventual paralysis.  The 
effects of ALS, however, are often not contained to the motor system, and may include some 
degree of cognitive and behavioral impairment typically believed to be associated with frontal 
lobe dysfunction, such as behavioral and emotional disinhibition, planning and problem 
solving difficulties, impulsivity, attention, and personality change (Neary, Snowden, Mann, 
Northern, Goulding, & Macdermott, 1990).  However, rapid physical deterioration may 
overshadow ALS patients’ cognitive deficits (Irwin, Lippa, & Swearer, 2007), which may 
range from subtle to severe.  Furthermore, these deficits may be related to problematic 
behaviors and thoughts across domains important to functioning.  Consequently, there is a 
need to clarify the prevalence and pattern of cognitive and behavioral deficits in ALS, which 
have a sizeable impact not only on the patients’ physical health and survival, but also on their 
sense of well being, or quality of life (QOL), as they approach the end of life.  
What is ALS? 
 Amyotrophic Lateral Sclerosis (ALS) is a motor neuron disease affecting 
approximately 30,000 people in the United States (ALS Association, 2004) that involves the 
progressive degeneration of upper and lower motor neurons, leading to muscle weakening and 
wasting, eventual paralysis, and death (commonly from respiratory failure) (NINDS, 2003).  
ALS comprises one major subtype of Motor Neuron Diseases (MND), which encompasses the 
group of neurological disorders involving disrupted communication between nerve cells in the 
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brain and those in the spinal cord.  Although ALS is synonymous with MND in North America 
and continental Europe (Bak, O’Donovan, Xuereb, Boniface, & Hodges, 2001; Goldstein, 
Atkins, & Leigh, 2002; NINDS, 2009), there are various subtypes of MND, based primarily on 
the site of motor neuron degeneration.  In particular, Primary Lateral Sclerosis (PLS), which is 
considered a variant of ALS, initially affects only upper motor neurons and typically has a 
slower rate of progression (NINDS, 2009).  Much research on MND however, encompasses 
individuals with MND in general, or does not specify the subtype(s) included in the sample.  
In fact, some experts suggest that ALS and PLS could be 2 points on a continuum of MND, 
and not distinct disorders (Tartaglia, Rowe, Findlater, Orange, Grace, & Strong, 2007).  
Therefore, throughout this paper, the term ALS will be inclusive of other subtypes of MND 
(i.e., PLS). 
No cure exists for ALS, and treatment options are similarly limited for both ALS and 
PLS.  Although ALS has a more relentless course than PLS and is often fatal, up to 10% of 
people with ALS may survive up to 10 years after symptom onset (ALS Association, 2004).  
On the other hand, PLS is not fatal and advances much slower (NINDS, 2009).  This 
highlights the need to examine the complete scope and trajectory of the disease course as well 
as psychological and personality factors that may influence patients’ treatment compliance, 
survival, and psychological well being, as well as that of the person providing their care. 
Cognitive Functioning in ALS 
 Although originally conceptualized as a purely motor disease, ALS is increasingly 
recognized as a multi-system disorder (Strong, 2001, 2008; Strong & Rosenfeld, 2003) that is 
“recognized to include cognitive impairment” (Wilson, Grace, Munoz, He, & Strong, 2001).  
However, how to best conceptualize the range and scope of extra-motor deficits in ALS 
remains a topic of debate.  It is clear that not all people with ALS have severe cognitive and 
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behavioral impairment, and thus it is increasingly believed that people with ALS “with and 
without cognitive impairment represent a disease continuum” (Ringholz, Appel, Bradshaw, 
Cooke, Mosnik, & Schulz, 2005, p. 589; Yang, Sopper, Leystra-Lantz, & Strong, 2003).  
Evidence that up to 50% of ALS patients exhibit mild cognitive impairment (Lomen-Hoerth, 
Murphy, Lagmore, Kramer, Olney, & Miller, 2003; Massman, Sims, Cooke, Haverkamp, & 
Appel, 1996; Ringholz et al., 2005) and approximately 15% of people with ALS meet criteria 
for frontotemporal dementia1 (FTD; Barson, Kinsella, Ong, & Mathers, 2000; Neary, 
Snowden, & Mann, 2000) suggests that cognitive decline may be a progressive feature of ALS 
(Ringholz et al., 2005), such that some degree of cognitive problems precedes more obvious 
motor impairments (Robinson, Lacey, Grugan, Glosser, Grossman, & McCluskey, 2006; 
Schriber et al., 2005), making the issue of cognitive impairment in ALS potentially relevant to 
all people with ALS.  Therefore, limiting the scope of interest to extensive impairment is 
dangerous for people with ALS who have less pronounced or sub-threshold deficits in domains 
critical to their functioning that affect treatment compliance, quality of life, and survival (Irwin 
et al., 2007; Olney et al., 2005). 
 While the prevalence of extra-motor impairment in ALS remains an area of debate, the 
most consistent pattern of cognitive and behavioral deficits target language skills (e.g., verbal 
fluency) and executive functions (EF) as measured by tasks of planning and problem solving 
abilities, inhibition, attention, cognitive flexibility, and verbal and non-verbal fluency 
(Abrahams, Leigh, Harvey, Vythelingum, Grise, & Goldstein, 2000; David & Gillum, 1986; 
                                                 
1 FTD involves frontal and temporal lobe atrophy and is characterized by pathological changes in 
language, perception, motor skills, memory, planning, behavior, and performance quality (Neary & 
Snowden, 1996).  
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Frank, Haas, Heinze, Stark, & Munte, 1997; Irwin et al., 2007; Massman et al., 1996; Strong, 
Grace, Orange, Leeper, Menon, & Aere, 1999; Talbot, Goulding, Lloyd, Snowden, Neary, & 
Testa, 1995). 
Executive Functions  
 Executive functions (EF) refer to a “wide range of cognitive processes and behavioral 
competencies which include verbal reasoning, problem-solving, planning, sequencing, the 
ability to sustain attention, resistance to interference, utilization of feedback, multi-tasking, 
cognitive flexibility, and the ability to deal with novelty” (Chan, Shum, Toulopoulou, & Chen, 
2008, p. 201).  Although there is general agreement that ‘executive functions’ is a non-unitary 
concept (Godefroy, Cabaret, Petit-Chenal, Pruvo, & Rousseaux, 1999) that enables the 
“control and regulation of lower-level cognitive processes and goal-directed, future-oriented 
behavior” (Alvarez & Emory, 2006, p. 17), there is less agreement regarding the best way to 
decompose ‘executive functions’ into sub-constructs (e.g., initiating, inhibiting, switching).  
Given that “a compelling theory of executive functions” is lacking (Miyake, Freidman, 
Emerson, Witzki, Howerter, & Wager, 2000, p. 50) and the absence of a gold-standard 
conceptualization of EF (Aron, 2008), studying EF can be difficult. This theoretical ambiguity 
likely contributes to another difficulty with research on EF- “the lack of a clear gold standard 
measure against which putative EF measures can be compared” (Royall et al., 2002, p. 381).  
First, although ‘executive’ and ‘frontal lobe’ tasks are often used interchangeably, “the use of 
executive function tests as ‘frontal lobe indicators’ is not warranted by the data” (Alvarez & 
Emory, 2006, p. 32).  While the frontal lobes may participate in functions deemed as 
‘executive’, other brain regions are also important to EF.   Second, most evidence suggests that 
measures of EF have low reliability and low intercorrelations (Alvarez & Emory, 2006; 
Miyake et al., 2000), which is not surprising if measures of ‘sub-constructs’ are compared.  
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Thus, the heterogeneous nature of EF suggests that quantifying EF using measures 
conceptualized at a higher level (as opposed to sub-construct level) might be unhelpful. 
One useful model of EF is Damasio’s (1995) somatic marker hypothesis, which 
distinguishes between logically-driven (“cold” functions) and emotionally-driven (“hot” 
functions) decision making (Bechara, Damasio, & Damasio, 2000).  Specifically, the “cold” 
component of EF enables activities such as planning, sequencing, utilization of feedback, 
multi-tasking, cognitive flexibility that are incorporated in traditional conceptualizations of 
EF.  Conversely, the “hot” components of EF involve emotional arousal, beliefs, and 
“regulation of one’s own social behavior” (Chan et al., 2008, p. 201).  Thus, emotionally 
triggered decision making is considered a “hot” function.  It is likely that these “hot” and cool” 
functions are mediated by related, but different regions of the brain (Bechara et al., 2000; 
Owen, McMillan, Laird, & Bullmore, 2005).  Evidence for this hypothesis is largely derived 
from the Iowa Gambling Task (IGT; Bechara, Damasio, Damasio, & Andersen, 1994), a task 
that assesses real-life decision making with regard to reward, punishment, and uncertainty.  
The IGT is considered more “ecologically valid” than traditional measures of EF (e.g., 
Wisconsin Card Sorting Test), as it adopts a more contextual and behavioral approach to 
examining EF in settings representative of “real-world” situations (Alvarez & Emory, 2006; 
Manchester, Priestly, & Jackson, 2004; Ready, Stierman, & Paulsen, 2001).  Thus, it is 
thought to better reflect “the nature of impaired executive functioning in everyday life” than 
standard neuropsychological tests that automatically control the environment (e.g., noise, 
distractions), direct behavior (e.g., prompting and stopping behavior), and limit affective 
arousal (Alvarez & Emory, 2006, p.1068; Manchester et al., 2004).   
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Executive Functions and Self-Regulation 
 There is general agreement, however, that EF broadly defined “control and regulate 
thought and action” (Friedman, Miyake, Corley, Young, DeFries, & Hewitt, 2006, p. 172), 
“enable us to formulate goals and plans” (Aron, 2007, p. 124), and are important to 
“independent and responsible social behavior” (Lezak, 1993, p. 30).  Likewise, self-regulation 
(SR) is “the ability to control or override one’s thoughts, emotions, urges, and behavior” and 
refers to processes that enable adaptive behavior and “flexibility necessary for…goal 
attainment” (Galliot et al., 2007, p. 325). 
 Both of these control resources are limited and can be exhausted, resulting in problems 
in controlling and regulating behavior and difficulty functioning in everyday life (Baumeister, 
Bratslavsky, Muraven, & Tice, 1998; Galliot et al., 2007; Marios & Ivanhoff, 2005; Miyake et 
al., 2000; Schmeichel, 2007; Vohs, Baumeister, & Ciarocco, 2005).  On the other hand, both 
can also be strengthened or enhanced through practice (Davidson, Zacks, & Williams, 2003; 
Muraven, Baumeister, & Tice, 1999; Oaten & Cheng, 2006).  Successful SR and executive 
control have positive outcomes (e.g., more effective coping skills, superior academic 
performance, less susceptibility to substance abuse, and reduced aggression; Galliot et al., 
2007).   
Although there are conceptual similarities between EF and SR (Kaplan & Brown, 
2010), they are often measured differently.  Specifically, EF is relatively content-free, often 
referring to unpracticed ability to perform cognitive operations (as measured by standard 
neuropsychological tests).  SR, on the other hand, is a content-rich, practiced function that 
gains meaning when interpreted within the context of real-life situations.  Thus, EF likely 
contributes to the ability to self-regulate in various situations.  Accordingly, Schmeichel (2007, 
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p. 251) suggests that “depleted self-regulatory resources may more precisely be considered 
instances of reduced resources for executive control”.   
Self-Regulatory Challenges in ALS 
 Although standard neuropsychological tests of EF may highlight cognitive deficits in 
ALS (e.g., FTD), there may be evidence of impairment in equally important areas, such as 
emotion regulation, social regulation, and the regulation of thought processes. 
 Emotional 
 According to Gross (1998), emotion regulation “refers to the processes by which 
individuals influence which emotions they have, when they have them, and how they 
experience and express these emotions” (p. 275). Thus, emotion regulation is conceptualized 
as a self-regulatory capacity that “involves the initiation of new, or the alteration of ongoing, 
emotional response through the act of regulatory processes” (Oschner & Gross, 2005, p. 242).  
Successful SR of emotions may depend on executive control, which is supported by evidence 
that the brain circuitry involved in the control of emotions overlaps with that involved in 
cognitive tasks measuring EF (Rule, Shimamura, & Knight, 2002; Taylor, Burkland, 
Eisenberger, Lehman, Hilmert, & Lieberman, 2008).  For example, inhibition likely 
contributes to successful performance on cognitive tasks (e.g., WCST) as well as the 
regulation of emotional expression. 
 Emotion regulation is particularly relevant in ALS.  Up to half of the people with ALS 
experience “sudden episodes of emotional display or pathologic laughing and crying (PLC)” 
(McCullagh, Moore, Gawel, & Feinstein, 1999, p. 43).  Even more, ALS patients with PLC 
performed significantly worse than ALS patients without PLC on the WCST (McCullagh et 
al., 1999).  Mood disturbances (e.g., depression, anxiety) may also be viewed as a failure to 
regulate emotions.  Some research suggests that negative affect is common in people with ALS 
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(Tedman, Young, & Williams, 1997) with 44% to 75% of patients with ALS having 
observable depression (Hogg, Goldstein, & Leigh, 1994; Tedman et al., 1997), and up to 42% 
of patients having anxiety in the medium to high ranges (Wicks, Abrahams, Masi, Hejda-
Forde, Leigh, & Goldstein, 2007). However, more recent evidence proposes that people with 
ALS have minimal or mild symptoms of depression (Gauthier et al., 2007; Kilani et al., 2004; 
Rabkin et al., 2005).  In sum, not all people with ALS exhibit grossly inappropriate emotional 
responses, which suggests that self-regulatory capacity to regulate one’s behavior and 
emotions may be an individual difference.  Hence, examining the range of these impairments 
as well as their impact on patient and caregiver well being is important.  
Social  
 Social interactions, including benign interactions such as coordinating interpersonal 
efforts (e.g., to solve a problem; Finkel, Campbell, Brunell, Dalton, Scarbeck, & Chartrand, 
2006), rely on self-regulatory capacity.  Furthermore, reduced self-regulatory resources result 
in passivity in social interactions.  Other research indicates that low-anxious, socially active 
people can expend the resources needed to overcome this passivity, but socially anxious 
people do not have these self-regulatory resources upon which to draw (Baumeister, Gailliot, 
DeWall, & Oaten, 2006). 
  Social relationships and support, albeit linked to high QOL in people with ALS 
(Simmons, Bremer, Robbins, Walsh, & Fischer, 2000), may require a great deal of SR to 
maintain. First, problems with communication (e.g., dysarthria; Strong, Grace, Orange, & 
Leeper, 1996), reduced verbal output, and eventual mutism (Bak et al., 2001) may limit social 
interactions.  Next, behaving in a socially appropriate way requires reasonably intact cognitive 
functions (e.g., attention, memory) and emotional control.  In fact, caregivers report that some 
patients “do not seem to understand or care about the feelings of others” (Grossman, Woolley-
9 
 
Levine, Bradley, & Miller, 2007, p. 56).  Altered social conduct in ALS is sometimes 
characterized by over-activity and unrestrained behaviors (e.g., “inappropriate disrobing, 
touching of staff, and/or inappropriate jokes”; Lomen-Hoerth et al., 2003, p. 1096) and 
sometimes characterized by apathy and lack of drive or initiative (Neary & Snowden, 1996). It 
seems most reasonable that this alteration in social conduct occurs progressively in some 
people with ALS, such that symptoms exist on a continuum that may be related or unrelated to 
the physical disease course. 
Thoughts 
 Cognitive inflexibility, or perseveration, may be among the cognitive deficits observed 
in ALS.  Perseveration, described as “repetitive, abstract, involuntary, and represent[ing] a 
failure of neuronal processes” (Thayer & Lane, 2002, p. 686), is characterized by an inability 
to adaptively adjust one’s thoughts.  This cognitive inflexibility makes it difficult to change the 
way one thinks and feels, which may interfere with one’s ability to cope with challenges or 
achieve goals.  Even more, perseveration is associated with rumination (Davis & Nolen-
Hoeksema, 2000). Ruminations are “perseverating self-focused thoughts” (Hertel, 1998, p. 
166) that can interfere with a person’s ability to inhibit thoughts, generate alternative ways of 
thinking about a situation, or switch the focus of one’s attention (Davis & Nolen-Hoeksema, 
2000; Watkins & Brown, 2002).  One study reported that nearly half of patients with ALS 
endorsed ruminating as a coping strategy and that higher rumination scores were related to 
higher depression (Hecht et al., 2002).  Despite the negative outcomes of perseverative 
thinking, patients perceive rumination as a helpful strategy (Earll, Johnston, & Mitchell, 1993).  
This may describe a more general tendency of people with ALS to engage in these 
perseverative thought processes, and may account for the lack of regulatory effort expended to 
overcome this tendency.  
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Repetitive thought is not always harmful (Segerstrom, Stanton, Alden, & Shortridge, 
2003), but several factors may make worry an unhelpful problem solving strategy for patients 
with ALS.  First, patients’ decision making may have little impact on their ultimate disease 
trajectory.  Second, patients’ prognosis is generally known to be poor, which may make certain 
forms of worry more maladaptive (Wilson, Centerbar, Kermer, & Gilbert, 2005).  Last, if 
patients’ self-regulatory resources are taxed or depleted, they might not only be more prone to 
perseverative thoughts, but have less strength to engage in alternative thought processes.  This 
highlights the importance of viewing perseverative cognitions along a continuum in relation to 
self-regulatory resources, such that at a mild or moderate level, perseverative cognitions may 
be less harmful (or even helpful), but at high levels (i.e., where inhibitory processes are 
ineffective), the consequences may be greatest. 
Physiological Self-Regulation in ALS 
Metabolic and autonomic resources may be important components of the capacity for 
executive control, and may be especially important for people with ALS.  First, EF are 
considered “metabolically expensive” in terms of the amount of glucose required to optimally 
function (Gailliot, 2008, p. 245).  Specifically, low levels of blood glucose and poor glucose 
tolerance have been linked to impaired performance on tasks involving processes that rely on 
executive function (i.e., Stroop Test; Benton, Owens, & Parker, 1994; Fairclough & Houston, 
2004) as well as SR (e.g., attention, impulsivity, emotion regulation; see Gailliot & 
Baumeister, 2008 for a review).  Furthermore, optimal levels and transport of glucose are 
linked to increased ability to exert self-control (Huisman, Gucht, Maes, Schroevers, Chatrou, 
& Haak, 2009) and better performance on cognitive tasks (Gailliot, 2008; Gailliot & 
Baumeister, 2008).  Thus, glucose is a resource that appears to be important to a person’s 
ability to self-regulate in various domains, including EF.  
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Given that glucose enables SR in multiple domains, glucose levels and tolerance may 
be especially important for people with ALS, who may be especially prone to self-regulatory 
deficits.  Indeed, there is evidence of impaired glucose transport in the cerebral cortex in some 
rat models of ALS (Guo, Kindy, Kruman, & Mattson, 2000).  Research has also revealed a 
link between mild frontal dysfunction and reduced glucose metabolism in the cortex and 
subcortical structures of ALS patients (Ludolph et al., 1992).  Low glucose levels and impaired 
glucose transport in people with ALS may partially account for impairments in self-regulatory 
and executive abilities, which are expensive in terms of glucose.  Specifically, for people with 
ALS who have low glucose levels and/or impaired glucose transport (e.g., poor glucose 
tolerance), executive impairments may be most pronounced.  On the other hand, adequate 
levels of glucose and optimal transport may enable people with ALS to self-regulate more 
successfully across domains. 
 Another potentially important physiological correlate of self-regulatory capacity is 
heart rate variability (HRV), an autonomic measure of beat to beat variations in heart rate that 
“reflects the ability to allocate and maintain attention, which are crucial to the control of 
emotion and performance” (Demaree, Pu, Robinson, Schmeichel, & Everhart, 2006, p. 162).  
HRV, like glucose, is associated with prefrontal activity and SR (e.g., inhibition, cognitive 
flexibility, delayed response).  Specifically, low resting HRV may correlate with decreased 
prefrontal activation, impaired EF, disrupted emotion modulation (i.e., enhanced/prolonged 
threat response), and perseverative thoughts (Brosschot, Thayer, & Gerin, 2006; Thayer, 
2007).  Low resting HRV also predicts less persistence on tasks requiring self-regulatory effort 
(Segerstrom & Solberg Nes, 2007).  Additionally, elevated heart rate (HR) and decreased HRV 
were independently associated with stressful events and worry (particularly worry about future 
events), when controlling for personality, mood, and demographic factors (Pieper, Brosschot, 
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Van der Leeden, & Thayer, 2007).  However, increased emotional display and impaired 
regulation of negative affect (e.g., anxiety, depression, hostility) have also been related to 
“reduced cardiac vagal control” (i.e., HRV) (Carney, Freedland, & Stein, 2000; Demaree & 
Everhart, 2004; Demaree, Pu, Robinson, Schmeichel, & Everhart, 2004; Friedman & Thayer, 
1998a, 1998b). 
There is converging evidence of impaired autonomic functions in ALS.  In fact, some 
suggest that “deterioration of sympathetic function is part of the disease process” (Oey, Vos, 
Wieneke, Wokke, Blakestijn, & Karemaker, 2002, p. 403).  ALS patients have “blunted vagal 
control” (i.e., decreased HRV; Pisano, Miscio, Mazzuero, Lanfranchi, Colombo, & Pinell, 
1995).  Interestingly, this sympathovagal imbalance is not correlated with disease severity.  
Not only may it be difficult to predict which people with ALS will suffer these cardiovascular 
deficits, those patients with more salient or obvious motor impairments may sometimes be 
more equipped to persist in the face of self-regulatory challenges than seemingly “intact” 
patients, further highlighting the importance of examining the full range of deficits in ALS, 
from sub-threshold to severe. 
It is possible that the metabolic demands and autonomic responses involved in exerting 
executive control and enabling SR are related.  In fact, Brook and Julius (2000) propose that 
autonomic imbalance is related to a range of cardiovascular abnormalities (including 
metabolic).  Decreased HRV has been linked to conditions involving impaired glucose 
metabolism (e.g., diabetes; Schroeder et al., 2005; Ziegler, Dannehl, Volksw, Muhlen, Spuler, 
& Gries, 1992). Taken together, these data imply that SR and EF are overlapping and related 
constructs that rely on a similar energy resource (e.g., glucose) and that have at least one 
common autonomic marker (e.g., HRV).  These cardiovascular and metabolic factors 
associated with SR may be particularly important for people with ALS.  It could be true that 
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the relationships between physiological factors (e.g., HRV, glucose) and SR are interactive.  
Self-regulatory fatigue may tax metabolic energy resources, making them less available for 
subsequent efforts at executive control, thereby resulting in the range of deficits noted in some 
individuals with ALS.  On the other hand, people with ALS may have impaired metabolic and 
cardiovascular functions that limit the success of their attempts to self-regulate, thereby 
resulting in the range of self-regulatory deficits in ALS. 
Self-Regulatory Deficits and Well-being  
 Deficits across psychological and physical domains may not only share a common 
mechanism (i.e., SR), but may also be interactive. For example, cognitive deficits (e.g., EF and 
social cognition) can lead to altered interpersonal and socio-emotional functioning 
(Zimmerman, Eslinger, Simmons, & Barrett, 2007).  Refined assessment of self-regulatory 
deficits across multiple domains may improve the prognosis of patients with ALS- not 
pertaining to their physical health, but to their well being or quality of life (QOL).  
Specifically, well being in a variety of domains (e.g., social, psychological, physical, 
existential) is important to overall QOL, while disease progression or loss of physical function 
appear to be less important to QOL (Averill, Kasarskis, & Segerstrom, 2007; Roach, Averill, 
Segerstrom, & Kasarskis, 2009).  In fact, when asked about the determinants of their own 
QOL, people with ALS refer to the importance of “psychological and existential issues, and 
support factors” rather than physical function (Simmons et al., 2000, p. 391).  In one group of 
people with ALS, decreased social support was the best predictor of psychological wellbeing 
and self-esteem (Goldstein, Atkins, Landau, Brown, & Leigh, 2006).  Evidence that higher 
QOL results in longer survival (Johnston, Earll, Giles, McClenahan, Stevens, & Morrison, 
1999; McDonald, Widenfeld, Hillel, Carpenter, & Walte, 1994) suggests that QOL is a 
“critically important endpoint in ALS” (Hardiman, Hickey, & O’Donerty, 2004, p. 233) and 
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that it should be a major focus of clinical care and interventions (e.g., Chio et al., 2004, 2005; 
Mitsumoto & DelBene, 2000). 
Reduced ability to self-regulate could result from decreased baseline capacity or from 
depleted executive resources due to the progressive and demanding disease course of ALS.  
Regardless of the cause, an inability to adaptively adjust and pursue one’s goals (explicit or 
implicit) ultimately influences the well being of people with ALS.  Thus, examining SR in 
ALS may enhance clinical interventions that tend to more narrowly focus on patients’ most 
extreme (often motor) deficits. 
Attending to the needs and well being of those providing the care for people with ALS 
is equally crucial, given that caregiver mental status influences patients’ physical, 
psychological and existential wellbeing (Rabkin, Wagner, & Del Bene, 2000).  Some even 
suggest that interventions to improve patients’ QOL should largely focus on caregivers, who 
support patients and relieve their distress, and that  health care providers should focus on 
improving the coping skills of caregivers (Chio et al., 2004).  Despite evidence that caregiver 
well being is important to patient well being, caregiving appears to take quite a toll on the 
QOL of these individuals.  Caregivers in one longitudinal study exhibited a significant 
increase of burden and depression over a 9-month period (Gauthier et al., 2007).  Thus, 
caregivers may be more psychologically vulnerable to patients’ disease-related physical 
deterioration than patients themselves.  Given that ALS is a multi-system disorder as described 
above, factors other than physical disease progression may also be important to caregiver 
QOL.  Specifically, “patient’s cognitive functioning is an important factor in determining the 
level of burden” of caregivers (Chio et al., 2005, p. 781).  Thus, examining the range of self-
regulatory deficits in ALS has implications for both patients and for those caring for them. 
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The Current Study 
 The aims of this study were to test the following hypotheses in patients and caregivers: 
 1.  There will be between-patient variability in EF and self-regulatory capacity.  
Specifically, examining the distribution of executive and self-regulatory impairments (with 
regard to emotions, thought processes, and social interactions) in patients will reveal 
continuous distributions of scores on measures of SR and EF, supporting the idea that deficits 
exist on a spectrum, rather than being discrete disease entities or classes, such as FTD. 
 2.  Patients’ and caregivers’ ratings of SR will be positively correlated (Adelman, 
Albert, Rabkin, Del Bene, Tider, & O’Sullivan, 2004) so that in general, as patients perceive 
more problems, caregivers also perceive more problems.  However, we expect mean-level 
differences (patients will rate their problems as less severe than caregivers rate their problems) 
as well as a non-linear relationship between patient and caregiver ratings of SR (as deficits 
increase, patient and caregiver reports will diverge, possibly because patients aren’t able to 
realistically evaluate their condition; Lezak, 1995) .  If patient and caregiver reports are 
moderately and linearly related, they will be combined into composite scores for SR and EF to 
test subsequent hypotheses. 
 3.  The third aim of this study is to establish the construct validity of EF and SR by 
examining relationships among reports of SR in various domains (e.g., global regulation, 
social regulation, emotional regulation, regulation of thought processes) and executive 
functions in “hot” and “cool” domains. Moderate correlations (r ≥ .30) between different 
measures of EF/SR and weaker relationships (r ≤ .10) with divergent measures would support 
the use of composite EF/SR indices.  
 4.  EF will contribute to self-regulatory capacity, even when controlling for potentially 
confounding variables (e.g., intelligence, ventilation status, etc.). 
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 5.  SR and EF will correlate with physiological measures of HRV and A1c.  
Specifically, HRV will be lowest and A1c will be highest in those patients with more self-
regulatory and executive deficits.   
 6.  Patients’ self-regulatory capacity, executive functioning, and physiological factors 
(i.e., baseline HRV and A1c) will contribute to QOL.  Specifically, more self-regulatory and 
executive impairment, lower baseline HRV, and higher A1c are expected to be associated with 
poorer QOL.  This may be especially true for caregivers. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright © Abbey R. Roach, 2010 
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Chapter Two 
Method 
Participants 
  Thirty-seven patients with motor neuron disease (31 ALS, 6 PLS) and their primary 
caregivers were enrolled in the study.  This sample provided adequate power (.90) to detect a 
large effect (r = .50) of SR on EF.  Demographic characteristics of the sample are provided in 
Table 1. The sample was representative of the population of individuals diagnosed with motor 
neuron disease with regard to gender and age (NINDS, 2003). 
 Thirty-seven caregivers were recruited to participate in this study.  However, 
demographic data were only available for 36 caregivers as 1 caregiver did not complete the 
questionnaires.  In general, men were more likely to be cared for by an opposite-gendered 
caregiver and females were more likely to have a same-sex caregiver.   
Procedure 
 Participants were recruited for the study though ALS clinics at the University of 
Kentucky and Cardinal Hill Rehabilitation Hospital in Lexington, Kentucky.  A letter was 
mailed to all ALS clinic patients informing them about the study.  Patients were encouraged to 
respond (via an enclosed response card or via their physician during their clinic visit) if they 
were interested in participating.  A research assistant followed up with each patient either in 
person or by phone to determine eligibility. 
To be eligible for participation, the following criteria were met: diagnosis of ALS 
(according to the El Escorial Criteria; World Federation of Neurology Research Group on 
Motor Neuron Diseases, 1998) or PLS (Pringle, Hudson, Munoz, Kiernan, Brown, & Ebers, 
1992), diagnosis greater than 6 months prior to participation, age between 30 and 90 years, no 
diagnosis of Type 1 Diabetes, fluency in English, and having a caregiver willing to participate.  
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Sixty-four patients expressed interest in this study.  Fourteen individuals initially expressed 
interest but declined to participate after hearing more about the study, 6 individuals cancelled 
their appointments and were not able to reschedule, 2 individuals were diagnosed within the 
past 6 months, 2 individuals were hospitalized with pneumonia prior to participating, 1 
individual was diagnosed with Type 1 Diabetes, and 2 individuals died before participating in 
the study.  Thus, 37 patients provided informed consent to participate in this study. 
Most patients were tested at Cardinal Hill Rehabilitation hospital (N=30).  However, 7 
patients were tested in their home because they were unable to travel to the testing site (e.g., 
due to mobility problems, lack of/cost of transportation, scheduling conflicts).  Upon arriving 
to the appointment, informed consent was reviewed with participants.   Caregivers were 
provided a packet of questionnaires to complete in a separate room.  Physiological equipment 
was attached to the patient, and the patient was instructed to sit and relax for 5 minutes to 
obtain baseline physiological measurements.  Upon completion of the 5 minute baseline 
period, participants completed 2 computerized neuropsychological tests, the physiological 
leads were removed, and 2 more neuropsychological tests (i.e., booklets) were administered.  
Questionnaires (assembled in counter-balanced order) were then verbally administered to 
patients by the principal investigator.  Patients responded to each item using a visual scale card 
provided.  Upon completing these questionnaires, a finger prick was administered to obtain a 
blood sample for measurement of A1c.  Patients were offered breaks as needed throughout the 
testing.  The range of time required to complete the protocol was between 2 and 3 ½ hours 
(Mean= 2.29 hours, SD= .34 hours). Participants were mailed $50 for participating in the 
study. 
Measures 
Descriptive Measures 
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 Demographics.  Demographic information (e.g., age, gender, ethnicity) was obtained 
from patients and caregivers (see Table 1).  Additionally, patients provided disease-related 
information (e.g., dates of diagnosis and symptom onset, onset site).  
Self-Regulation Measures 
 Revised Dyadic Adjustment Scale-cohesion scale (RDAS; Busby, Crane, Larson, & 
Christensen, 1995).  This is a 16-item self-report measure of relationship quality developed for 
married or similar, cohabiting dyads.  The revised version of the scale contains 3 subscales 
(consensus, satisfaction, and cohesion) in addition to the total score.  The 4-item cohesion 
subscale (α=.80) was used in the current study to focus on patients’ social SR with the 
individual providing their care.  This subscale is composed of items that are not specific to 
marital dyads (e.g., “how often do you and your [caregiver] work on a project together?”).  
Lower scores indicate better relationship cohesion. The internal consistency of this scale in the 
current sample was .81 for patients and .75 for caregivers. 
 Brief Fear of Negative Evaluation scale (BFNE; Leary, 1983). This self-report measure 
of social anxiety (e.g., apprehension about being negatively evaluated, avoiding being 
evaluated, and expecting the receipt of negative evaluation) consists of 12 items scored on 5-
point Likert-type scales.  The scale was selected due to evidence that self-regulatory capacity 
determines whether an individual is successful at overcoming social anxiety, which is shared, 
to a certain extent, by all individuals (Baumeister et al., 2006).  Lower scores on this scale are 
more adaptive (i.e., indicative of less social anxiety). The internal consistency of this scale in 
the current sample was .94 for patients and .96 for caregivers’ reports of patients. 
 Center for Neurologic Study- Lability Scale (CNS-LS; Moore, Gresham, Bromberg, 
Kasarskis, & Smith, 1997).  This is a 7-item self-report measure of affective lability in patients 
with ALS.  The scale consists of 2 subscales, labile laughing (4 items) and labile tearfulness (3 
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items), both of which have acceptable internal consistency (.91 and .89, respectively).  
Participants respond on a 5-point Likert scale, with higher scores indicative of more emotional 
lability or dysregulation.  The internal consistency of this scale in the current sample was .86 
for patients and .78 for caregivers’ reports of patients. 
 Rumination Scale (RS; Martin, Tesser, & McIntosh, 1993).  This was originally a 10-
item self-report measure of conscious, repetitive, persistent, aversive thought that is best 
described by a two-factor solution (Segerstrom et al., 2003).  The 4-item lack of control over 
thoughts/ distractibility scale was used as a measure of ability to regulate one’s thought 
processes in the current study.  However, the internal consistency of this 4-item scale was poor 
for both patients and caregivers in the current sample. The deletion of 1 item (i.e., “If I don’t 
want to think about something, I am able to just stop thinking about it.”) from the scale 
improved the internal consistency of patients and did not significantly affect that of caregivers, 
resulting of alphas of .53 and .62, respectively. Lower scores on this scale represent better 
ability to regulate one’s thought processes. 
Behavioral Rating Inventory of Executive Functions (BRIEF; Roth, Isquith,  
& Gioia, 1996).  This is a 75-item measure of executive regulation of behavior with self- and 
informant-report forms.  This inventory consists of nine non-overlapping empirically derived 
clinical scales that measure various aspects of executive functioning as applied to daily life 
(Inhibit, Self-Monitor, Plan/Organize, Shift, Initiate, Task Monitor, Emotional Control, 
Working Memory, Organization of Materials), that form two broader indexes of behavioral 
regulation and meta-cognition.  Both the scales and indexes have adequate internal 
consistency, ranging from .73-.90 for clinical scales and .93-.96 for indexes on the self-report 
form and .80-.93 for clinical scales and .95-.98 for indexes on the informant-report form.  This 
scale is appropriate to measure a variety of forms of SR, both from the patients’ and 
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caregivers’ perspectives.  In the current study, several items were deleted to prevent overlap 
with disease symptoms.  Specifically, items that were believed to be overlapping with the 
physiological disease process involved in ALS or PLS (e.g., “taps fingers or bounces legs”, 
“has trouble sitting still”, “lies around the house a lot”) were not included in the total score.  
The total score was used in the current study as a self-reported measure of global regulation 
with higher scores indicating worse global regulation. 
Neuropsychological Measures  
 Iowa Gambling Task (IGT; Bechara et al., 1994).  This computer-administered task 
assesses “real-life” decision making ability in an “ecologically valid” paradigm in accordance 
with Damasio’s (1995) somatic marker hypothesis.  Participants are instructed to choose one 
of four decks (A, B, C, D; 60 cards each) until 100 selections have been made. After each 
selection, participants receive a reward and/or penalty in play money. The decks have pre-
determined rewards and penalties (e.g., Decks A and B have a high rewards and penalties, 
decks C and D have low rewards and penalties). Additionally, decks A and C have more 
frequent penalties and decks B and D less frequent penalties. A greater selection of cards from 
decks A and B (disadvantaged decks) results in a net loss and a greater selection of cards from 
decks C and D (advantage decks) results in a net gain.  The performance measure used in this 
study was the number of cards picked from advantaged decks minus the number of cards 
picked from disadvantaged decks.  After reversing the direction of this scale, lower scores 
indicate better “hot” executive function. 
 Wisconsin Card Sorting Test (WCST; Berg & Grant, 1948).  This task requires 
participants to sort response cards (i.e., according to color, shape, and number) according to 
feedback (i.e., right or wrong) until they have matched six categories or sorted all 128 cards.  
The sorting rules change after 10 consecutive correct card sorts, requiring participants to 
22 
 
demonstrate cognitive flexibility to shift sets. The performance measure used in the current 
study was the number of perseverative errors, which represents cognitive inflexibility or 
failure to shift sets in response to changing demands (Ridderinkhof, Span, van der Molen, 
2002).  Although there is controversy surrounding the validity of this test as a measure of EF, 
it is the most frequently used measure of EF and is viewed as a “sensitive but not specific 
marker of frontal lobe damage” (Alvarez & Emory, 2006, p. 19).  Lower scores indicate better 
“cool” executive function. 
 Benton’s Judgment of Line Orientation-Form H (BJLO; Benton, Varney, & Hamsher, 
1978).  This is a standardized measure of “pure” visuospatial processing used to provide 
discriminant validity for EF. The spiral-bound booklet contains 35 stimuli (i.e., 5 practice 
items, 30 test items) with 11 response choices (i.e., lines).  Validity and reliability of this task 
are high (.84; Riccio & Hynd, 1992).  Higher scores indicate better visuo-spatial skills. 
Autonomic Functioning: Heart Rate Variability (HRV)   
HRV is a measure of parasympathetic control over the heart that is an index of self-
regulatory capacity (Segerstrom & Solberg Nes, 2007).  Parasympathetic activity leads to 
more variable intervals between heart beats, and therefore higher HRV.  The Ambulatory 
Monitoring System (Vrije Universiteit, Amsterdam, The Netherlands) was used during a 5-
minute baseline period (prior to the administration of any other measures) to produce an 
electrocardiogram (and provide indexes of HR and HRV), with leads attached to the forearms 
and leg in a Lead II configuration.  The electrocardiogram was sampled at 1,000 samples/s.  
Beats per min and mean squared successive differences in the inter-beat interval (HRV) were 
calculated on-line and stored in 30-second epochs.  HRV was calculated as the root mean 
squared successive differences in the inter-beat interval (Task Force of the European Society 
of Cardiology and the North American Society of Pacing and Electrophysiology, 1996) and 
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was examined in relation to self-regulatory abilities across domains as assessed by self-report 
measures and neuropsychological testing. 
Metabolic Functioning:  Glycosylated Hemoglobin 
Hemoglobin A1c (A1c) was measured to assess the overall effectiveness of blood 
glucose control over the past 2-3 months.  Given that the long-term self-regulatory capacity 
and its practical impact on functioning were of interest in the current study, A1c was an 
appropriate glucose test as it reflects the course of glucose control over a more extended time 
period than other glucose measures and therefore, it is less sensitive to short-term fluctuations.  
The optimal level of A1c is debated, but it is generally suggested the estimate not exceed 6% 
for normal individuals and 7% for diabetic individuals (American Diabetes Association, 2007).  
Thus, lower values generally reflect “better” functioning.  This measure was taken on site 
using the A1c NOW+ monitor (Metrika), which involved obtaining a drop of blood via finger 
stick delivered by a lancet device. 
Well-being Measures 
McGill Quality of Life Questionnaire (MQOL).  This is a 16-item self-report scale 
measuring subjective well being in terminally ill populations (Cohen, Mount, Strobel, & Bui, 
1995).  Four of the five sub-scales relating to physical well being, psychological well being, 
existential well being, and social support comprise a total score (α=.80), which was used in the 
current study (i.e., the 3-item physical symptoms subscale will be excluded).  Items are 
measured on a Likert-scale ranging from 0 to 10, with lower scores indicating poor quality of 
life and higher scores indicating good quality of life.  The internal consistency of patients on 
this scale was .90. 
Quality of Life in Life Threatening Illness Family Carer Version (QOLLTI-F; Cohen, 
Leis, Kuhl, Charbonneau, Ritvo, & Ashbury, 2006).  This is a 16-item measure of caregiver 
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well being that takes the perception of the condition of the patient into account.  This scale, 
derived based on what caregivers state is most important to their well being, is composed of 7 
domains (i.e., carer’s own state, environment, carer’s outlook, quality of care, relationships, 
patient condition, financial) that have acceptable internal consistency (∝=.48 (environment)- 
.81 (carer’s own state)) as well as test-retest reliability (.50-.79).  The internal consistency of 
the total score (i.e., the average of the 7 domain scores) in this caregiver sample was .90.  
Higher scores indicate better QOL. 
Revised Dyadic Adjustment Scale-satisfaction item (RDAS; Busby et al., 1995).  
Patients and caregivers rated their current satisfaction in their relationship on a 0-100 scale (0= 
completely unhappy, 100=completely happy). 
Potential Confounds 
 Functional Status.  The ALS Functional Rating Scale (ALS-FRS) is a 12-item self-
report scale used to assess activities of daily living for people with ALS (e.g., speech, 
handwriting, dressing/hygiene, walking; ACTS, 1996).  The scale consists of 4 scales relating 
to coordinated upper limb motions, bulbar function, breathing, and gross, less finely controlled 
activities.  The total score averages item responses (α=.90).   Item test-retest reliability has 
been demonstrated (≥.88). Consensus ratings between patients and caregivers assess the 
difficulty of specific tasks.   Lower scores on a 1 to 4 scale indicate more functional difficulty.  
The internal consistency of this scale in the current study was .83.  
 Intelligence.  Standard Progressive Matrices (SPM; Raven, 1948) is a multiple-choice, 
non-verbal abstract reasoning test that is one component of Spearman’s g (general intelligence; 
Strauss, Sherman, & Spreen, 2006).  This 60-item test involves patients selecting one missing 
piece from 6 or 8 alternative missing pieces to complete a stimulus figure.  The test has high 
internal consistency (> .70; Burke, 1985) and test-retest reliability (>.80; Raven, 2000). 
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Data Analysis 
 Alpha was set at .05, two-tailed, for all inferential tests.  Continuous predictors were 
centered prior to regression analyses. 
Missing data were imputed from the available data using SPSS Missing Value 
Analysis.  This procedure imputes missing values through expectation maximization (EM) 
algorithms.  Reasons for missing data included: patient fatigue, time constraints, inability to 
reschedule, and caregiver non-response.  The following is the breakdown of missing variables 
that required imputation.  For patients, data were imputed for the BRIEF-A, JLO, RS, CNSLS, 
FNE, and MQOL for 1 individual each.  For caregivers, 2 participants failed to complete the 
BRIEF-A Informant Report and 1 participant failed to complete all questionnaires including 
demographics and SR measures.  However, these data are believed to be missing at random 
(MAR), which is a typical and relatively safe assumption, and thus accommodated by our 
analyses (Schafer & Graham, 2002).  
 Prior to primary analyses, preliminary analyses were conducted.  First, despite having 
small sample sizes, t-tests and chi-square tests examined demographic differences between 
patients with ALS (N=31) and PLS (N=6).  ALS and PLS patients significantly differed with 
regard to gender (X2 (1, 37) = 4.03, p < .05) and marital status (X2 (1) = 12.15, p < .01), such 
that ALS patients were more likely to be male and married than PLS patients. However, t-tests 
revealed a lack of significant differences between these groups on nearly all substantive 
variables.  Only 1 of the 18 comparisons was significant at p < .05.   When comparing A1c 
values of patients without diabetes to those with type 2 diabetes (N=3), there were no 
significant differences, suggesting that diabetes status should not be statistically controlled in 
analyses.   
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The test of Hypothesis 1 primarily involved exploratory data analyses to examine the 
distributions of each dependent variable.  First, univariate analyses (i.e., descriptive statistics 
and scatterplot/boxplot examination) revealed outliers in the data, the degree and direction of 
asymmetry of the distribution (skewness), and the peakedness of the distribution (kurtosis) of 
each variable.  Given that skewness statistics can be misleading, especially in small samples, a 
conservative approach was taken in evaluating when to remove outliers or transform data.  In 
this study, variables with skewness statistics that were ≥ 2 standard errors were examined for 
removal of outlier(s) and considered for transformation.  However, given that there is no 
universally applicable rule of thumb in interpreting these estimates, histograms and residual 
plots were closely examined before data transformation.  When appropriate, data were log 
transformed to achieve a normal distribution.  This examination of the distribution of values 
not only identifies whether deficits exist on a continuum or not, but it also informs whether 
there are subsequent constraints on r and whether the assumptions of regression analyses are 
violated with regard to linearity and normality of the dependent variables.   
 The test of Hypothesis 2, regarding patient-caregiver agreement, involved 4 primary 
components.  First, paired samples T-tests were conducted to examine mean-level differences 
between patients and caregivers.  Next, a correlation matrix was calculated to determine if 
there is a positive (e.g., moderate) correlation between raters.  Next, scatterplots were 
examined to detect curvilinearity.  Finally, non-linear relationships were then entered into a 
curve estimation regression (simultaneously) to examine the nature of the relationship. 
Post-hoc analyses were conducted to examine discrepant patient-caregiver ratings of 
SR.  First, this involved the creation of a discrepancy score (patient rating-caregiver rating) for 
each scale on which there was disagreement between patient and caregiver reports.  Next, 
these discrepancy scores were regressed onto the neuropsychological measures of EF to 
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determine whether differences in executive functioning contributed to patient-caregiver 
discrepancies.  The first step included the main effects (i.e., “cool” EF, “hot” EF) and the 
second step included the main effects and their interaction (“cool” EF* “hot” EF).  The 
interactions were probed to examine the nature of the differences between the main effects for 
patients and caregivers. Last, repeated-measures regressions examined within-subject effects 
of person (i.e., patient v. caregiver) on the interaction between “cool” EF and “hot” EF 
performance in predicting SR.  The “person” factor had 2 levels (i.e., patient report and 
caregiver report) and the 3 covariates were performance on the WCST, IGT, and the 
interaction (i.e., WCST*IGT). 
 A similar procedure was used to test Hypothesis 3, which involved computation of a 
correlation matrix to examine the relationships among the various measures of SR and EF.  
The use of composite indices of EF (e.g., “cool” EF, “hot” EF) and SR (e.g., emotional 
lability, rumination, social anxiety, dyadic cohesion, and global regulation) would be justified 
by moderate to high correlations (r ≥ .30) with related constructs and weaker relationships (r ≤ 
.10) with divergent measures.  A lack of support for composite constructs would result in each 
scale being examined separately in subsequent analyses. 
Zero-order correlations were examined to test Hypothesis 4, that superior “hot” and 
“cold” EF would be associated with better self-regulatory ability across domains.  The need to 
statistically control for some variables (e.g., intelligence, time of assessment, respiratory 
functioning, and functional status) was examined.  In general, examination of partial 
correlations revealed that the relationship between caregiver ratings of rumination and 
patients’ “cool” EF may be attributed to the overlap between IQ and EF. 
The test of Hypothesis 5 was similarly conducted by examining zero-order correlations 
among facets of SR and measures of physiological functioning.  Again, the need to statistically 
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control for some variables (e.g., intelligence, time of assessment, respiratory functioning, and 
functional status) was explored, but was largely unnecessary given the lack of significant 
relationships. 
Hypothesis 6 involved the computation of a correlation matrix to determine if better 
self-regulatory abilities and physiological functioning would predict better QOL and more 
relationship satisfaction for patients and caregivers. Again, given the lack of relationship 
between potential confounders (e.g., age, gender, time of assessment, ventilation status, and 
functional status) and the variables of interest (i.e., QOL, relationship satisfaction), no 
statistical controls were included in analyses and zero-order correlations were sufficient to 
examine these relationships.  Additional hierarchical regressions were employed to examine 
the unique contribution of caregiver ratings to patients’ ratings of QOL, above and beyond 
patient ratings, and vice versa.  Thus, patient QOL was regressed onto patient ratings of SR in 
step 1 and caregiver ratings of SR in step 2.  Similarly, in a second regression, caregiver QOL 
ratings were regressed onto caregiver ratings of patient SR in step 1 and patient ratings in step 
2.  
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Table 2.1 
Descriptive Characteristics of Sample      
Variable     Patients   Caregivers  
Age     59.97 (11.57)   58.33 (13.31) 
Gender 
Male    54.1 % (N=20)  27 % (N=10)   
Female   45.9% (N=17)  70 % (N=26) 
Ethnicity 
Caucasian   97 % (N=36)   95 % (N=35) 
Latino    3 % (N=1)   3 % (N=1) 
Marital Status 
 Married   84 % (N= 31) 
 Divorced   8 % (N= 3) 
 Widowed   5% (N= 2) 
 Single    3% (N=1) 
Education (years)   13.81 (3.73)    
Household Income (annual)  $53,151 ($32,477)   
Disease Type:  
ALS    84 % (N=31) 
 PLS    16 % (N=6) 
Onset Type:  
Limb    78 % (N=29) 
 Bulbar    22 % (N=8) 
Months Since Diagnosis  36.02 (34.52) 
Months Since Onset   57.65 (42.66) 
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Functional Status (ALS-FRS)  30.66 (9.19) 
Response Mode: 
Verbal    81 % (N=30) 
 Non-Verbal   19 % (N=7)      
Note.75% of the patients’ caregivers were a spouse living in the same household 
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Chapter Three 
Results 
Distribution of SR and EF in Patients 
Descriptive statistics revealed that most continuous variables were normally 
distributed.  Examination of skewness statistics, scatterplots, and boxplots revealed no 
problematic outliers or significant skewness for most variables (see Table 2).  However, there 
were 2 variables for which the skewness statistic was ≥ 2 standard errors, which warranted 
consideration for transformation.  Upon examining the distribution of the WCST variable 
(skewness = 1.04, SE=.39), the slight positive skew looked acceptable on a boxplot.  There 
were no significant outliers and data were continuously distributed. Thus, this variable was not 
transformed.  On the other hand, the HRV data (i.e., MSSD), which was also positively 
skewed (skewness = 2.94, SE=.39), evidenced several outliers.  These outliers were closely 
examined and considered for removal from the data.  However, only 2 data points (426.60, 
592.67) were removed due to them falling outside the typical range of MSSD values (i.e., < 
290) as established in a large undergraduate sample (N=166) using the same equipment and 
software.  The other outliers (274.22, 238.08, 182.46) were not removed because they were 
within the range of reasonable MSSD values.  The removal of these 2 outliers however, did 
not entirely correct the skewness of this variable. Thus, the data was also log transformed (i.e., 
log10) to achieve a normal distribution (skewness =.34, SE=.40). 
Thus, normal and continuous distributions suggest that self-regulatory and executive 
impairments in ALS do exist on a spectrum, rather than as discrete disease entities, as 
predicted in Hypothesis 1. 
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Patient-Caregiver Agreement 
The first part of Hypothesis 2 proposed positive correlations between patient and 
caregiver ratings of patient SR function.  The correlations in Table 3 revealed that patient-
caregiver agreement in rating SR and EF ranged from weak to strong, but was generally 
positive (range: -.14-.58; mean r = .10).  Specifically, there was strong agreement with regard 
to emotional lability (r = .58; p < .01), such that as caregivers perceived more lability, patients 
also perceived more lability.  Likewise, there was a moderate to strong positive relationship 
between patients’ and caregivers’ report of patients’ social anxiety (i.e., BFNE; r = .43, p < 
.01).  Patient and caregiver reports of patients’ global regulation were also moderately 
correlated (r = .31, ns).  However, there was less patient-caregiver agreement on cohesion (r = 
.19, ns), and there was virtually no relationship between patient and caregiver ratings of 
rumination, that is, patients’ ability to regulate thought processes (r = .15, ns), indicating that 
patient-caregiver reports of relationship cohesion and patient ability to regulate thought 
processes were more discrepant.  Therefore, this part of Hypothesis 2 was partially supported:  
Moderate to high patient-caregiver agreement characterized emotional and more global 
measures of patient SR, but there was little agreement on cognitive measures of SR and, 
surprisingly, on cohesion in the patient-caregiver relationship. 
The second part of Hypothesis 2 proposed mean differences between patients and 
caregivers such that patients would perceive themselves to have better SR function than would 
caregivers.  Table 3 includes means and standard deviations for the SR measures for patients 
and caregivers.  Paired samples T-tests revealed no significant mean level differences between 
patient and caregiver ratings of emotional lability (t(1, 35) = 1.74, ns) or social anxiety (t(1, 
35) = 1.26, ns). However, there was a significant difference between patient and caregiver 
reports of patients’ global regulation (t(1, 35) = 2.15, p < .05), such that caregivers perceived 
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patients to be functioning better than patients perceived themselves to be functioning.  There 
was also a significant difference between patient and caregiver reports of relationship cohesion 
(t(1, 35) = 2.27; p < .05), where caregivers perceived more cohesion than patients.  Therefore, 
these results are opposite the predicted pattern in Hypothesis 2, which suggested that patients 
would perceive themselves to be functioning better than caregivers perceived them to be 
functioning. 
The final part of Hypothesis 2 proposed that disagreements between patient and 
caregiver reports could arise from nonlinear relationships or patients’ cognitive function.  
These possibilities were explored with regard to cohesion and rumination, where there was 
disagreement.  Curve estimation regression revealed a non-linear, quadratic relationship 
between patient and caregiver reports of dyadic cohesion (β=.42, F(2,36)= 4.27, p < .05, ΔR2= 
.16).  Although there was a tendency for patients to rate cohesion as low compared to 
caregivers, the highest agreement occurred at lower scores (i.e., when cohesion was higher) 
and to a lesser degree, at agreement at higher scores (i.e., when cohesion was lower).  While 
caregivers perceived high cohesion and patients perceived low cohesion in some instances, the 
opposite pattern in which patients perceived high cohesion and caregivers perceived low 
cohesion, did not emerge (see Figure 1).  Post-hoc analyses of patient-caregiver discrepancies 
on rumination and cohesion attempted to examine the contribution of EF to these 
discrepancies. Thus, the discrepancy score for each scale was regressed onto EF measures 
(WCST, IGT) in separate analyses. A lack of significant effects (rumination discrepancy 
→”cool” EF: t(1,35)= 1.19, ns; rumination discrepancy →”hot” EF: t(1,35)= .02, ns; cohesion 
discrepancy →”cool” EF: t(1,35)= 1.82, ns; cohesion discrepancy →”hot” EF: t(1,35)= -.17, 
ns) indicated that these discrepant views of patient’s self-regulatory capacity could not be 
explained by differences in executive capacity. 
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However, it was suspected that the interaction of the EF measures (WCST*IGT) may 
account for more variance in SR than each measure alone.  Also, to explore whether the effects 
of the interaction on SR differed depending on the rater (e.g., patient v. caregiver), repeated 
measures regressions examined the within-subject effect of person on the interaction between 
“hot” and “cool” EF.  There was a tendency (p < .10) for the interaction to predict dyadic 
cohesion differently for patients and caregivers.  For patients, good “hot” EF was associated 
with more cohesion only if there was also good “cool” EF.  Good “hot” EF was associated 
with less cohesion if there was poor “cool” EF for patients.  Poor “hot” EF was generally 
related to less cohesion for patients, and this was most true if patients had good “cool” EF (see 
Figure 2). The opposite pattern emerged for caregivers, such that poor “hot” EF was generally 
associated with more cohesion, and this was most true if patients had good “cool” EF.  On the 
other hand, good “hot” EF was associated with more cohesion if there was poor “cool” EF (see 
Figure 3).  Finally, when patients had good “cool” EF, caregivers rated patients as less likely 
to ruminate, and this was especially true when patients also had good “hot” EF. 
Thus, results partially align with Hypothesis 2, in that there was a non-linear 
relationship between patient and caregiver ratings of dyadic cohesion.  However, patients and 
caregivers agreed most when both perceived more cohesion. This pattern was not explained by 
“hot” or “cool” EF. 
Are Self-Regulation Measures Unitary?  
 The first part of hypothesis 3 aimed to establish construct validity for SR.  A 
correlation matrix revealed that the relationships among various domains of SR varied for both 
patients (see Table 4) and caregivers (see Table 5).  Patients’ reports of SR capacities in 
different domains were generally in the weak to moderate range (range: -.17-.60; mean r = 
.20), and were less consistent than caregivers’ (range: -.13-.51; mean r = .30).  There was a 
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strong, positive correlation between patients’ reported social anxiety and rumination, such that 
as patients perceived less social anxiety, they perceived less rumination (r = .60, p < .01).  
Patients’ global regulation correlated most strongly and consistently with other measures of 
self-regulation.  Thus, as patients perceived themselves as having more global regulatory 
ability, they perceived themselves as being less emotional labile, less ruminative, and less 
socially anxious. On the other hand, better global regulation was related to perceptions of less 
dyadic cohesion. 
In general, a similar pattern emerged for caregivers (see Table 5).  However, the 
relationships among caregiver reports of patients’ SR across domains were generally stronger.  
Specifically, caregivers perceptions of emotional lability, social anxiety, and dyadic cohesion 
converged, such that better functioning in one domain was associated with better functioning 
in the other domains.  Similarly caregiver ratings of patient tendency to ruminate was related 
social anxiety in the expected direction, with more rumination associated with more social 
anxiety.  As was true for patients, caregiver rated global regulation was most strongly and 
consistently correlated with other measures of SR.  As caregivers rated better global 
regulation, they also rated less emotional lability, less rumination, less social anxiety, and to a 
lesser degree, more dyadic cohesion (r = .15, ns).  This divergence among domains of self-
regulation, which was particularly evident for patients, does not support Hypothesis 3 or the 
use of composite indices of SR that combine measures of SR into a single index.  In general, 
caregivers perceived a more pervasive pattern of deficits (evidenced by higher correlations 
across measures) compared with patients, who viewed their deficits to be less cohesive and 
more idiosyncratic.   
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Are Cognitive Measures Unitary? 
The second part of Hypothesis 3 aimed to examine the construct validity of EF. A 
correlation matrix (Table 6) revealed that although there was a small to moderate relationship 
between measures of “hot” and “cold” EF as expected, there was sufficient evidence to 
conceptualize these as distinct EF components.  While there was a divergent relationship 
among measures of EF and visuo-spatial skills, intelligence was consistently associated with 
the other cognitive measures.  Therefore, the subsequent correlations among “hot” EF, “cold” 
EF, and SR measures statistically controlled for intelligence.  Hypothesis 3 was supported in 
that “hot” and “cool” EF were more strongly correlated to one another than to an unrelated 
construct.   
How much does EF contribute to SR? 
Hypothesis 4 proposed that EF would contribute to SR.  Given the lack of support for 
composite SR and EF constructs, “hot” and “cool” components of EF were examined in 
relation to individual domains of SR (i.e., thought regulation, social anxiety, emotion 
regulation, global regulation), primarily using zero-order correlations.  However, given the 
significant relationship among intelligence and both EF and SR constructs, a separate set of 
correlations controlled for intelligence (see Table 7).  Specifically, higher intelligence was 
related to better “hot EF” (r = -.34, p < .05), more social anxiety (patient rated; r = .35, p < 
.05), less dyadic cohesion (caregiver rated; r = .47, p < .01), and less rumination (caregiver 
rated; r = -.41, p < .01).  There was no need to statistically control for other suspected 
confounds (e., respiratory functioning, time of assessment, and functional status).  
Correlations between EF performance and SR reports were generally in the small to 
medium range.  Better “cool” EF significantly correlated with less rumination by caregiver 
report (but not by patient report).  This relationship was no longer significant when 
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intelligence was partialled out.  Smaller, non-significant correlations suggested that better 
“cool” EF also related to better relationship cohesion by patient report, but worse cohesion by 
caregiver report.  There were no significant correlations between “hot” EF and SR. Again, 
smaller, non-significant correlations suggested that better “hot” EF was related to better 
relationship cohesion by patient report and worse cohesion by caregiver report.  This pattern of 
results is largely reflected in Figures 2 and 3, which show the effects of EF on patient and 
caregiver reports of cohesion. 
In sum, the contribution of EF to SR depended on several factors, including the EF 
component (i.e., “hot” v. “cool”), the individual rating patient self-regulatory capacity, and the 
domain of SR.  Consequently, Hypothesis 4 is partially supported. 
Physiological Functioning: Does EF or SR matter? 
 Hypothesis 5 proposed that better “cool” and “hot” EF, and better ability to self 
regulate across domains, would be associated with more optimal metabolic (i.e., lower A1c) 
and autonomic functioning (i.e., higher HRV).  First, though not an explicit hypothesis, better 
physiological health was expected to converge across measures of metabolic and autonomic 
functioning.  However, this relationship between A1c and HRV did not hold (r = -.05; ns).  
Thus, support for the hypothesized relationships between EF and SR were limited by the 
divergence of these two physiological measures. 
 As shown in Table 8, correlations among autonomic functioning (i.e., HRV) and 
measures of SR and EF were generally in the small to medium range.  For patients, less 
emotional lability was significantly related to higher (i.e., more optimal) HRV.2  On the other 
hand, better “cool” EF was significantly related to lower HRV.  Smaller, non-significant 
                                                 
2 A significant relationship between HRV and patient age (r = .45, p < .01), did not significantly change the 
relationship between emotional lability and HRV or the relationship between WCST performance and HRV when 
it was statistically controlled in step 1 of a hierarchical regression. Thus, to preserve power (i.e., more df), zero-
order correlations were preferred.  
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correlations suggested that less rumination, less social anxiety, and more global regulation 
were related to higher HRV and better autonomic functioning.  While there were no significant 
relationships between caregiver rated SR and patients’ HRV, correlations revealed a 
relationship between less emotional lability, more relationship cohesion, less social anxiety, 
better global regulation, and higher HRV.  In sum, as expected in Hypothesis 5, better 
autonomic functioning was related to better SR in several domains (albeit these relationships 
were not always statistically significant). However, “hot” and “cool” EF did not relate to HRV 
in the expected direction, as better EF was associated with lower (i.e., worse) HRV. 
 Correlations among measures of SR, EF, and metabolic functioning were generally 
smaller in magnitude than those with autonomic functioning, and this was most true for 
patients.  Although largely non-significant, correlations were generally small to moderate in 
size.  There was convergence between patient and caregiver ratings of global self-regulation, 
such that better perceptions of global self-regulation were significantly associated with better 
regulated glucose (i.e., lower A1c)3.  Smaller, non-significant correlations indicated that the 
pattern of relationships was stable for both patients and caregivers, such that for both raters, 
less emotional lability, less rumination, less social anxiety, better global regulation, and more 
dyadic cohesion were associated with lower (i.e., better) A1c values.  Again, Hypothesis 5 was 
partially supported with regard to the relationships between metabolic functioning and global 
self-regulation.  However, on the whole, results did not converge across measures of 
physiological functioning suggesting that different components of SR and EF may be more or 
less important for optimal physical functioning, depending on the physiological parameter 
examined.  
                                                 
3 A significant relationship between A1c and time of assessment (r = .38, p< .05), did not significantly change the 
relationship between global regulation and A1c for patients or caregivers. Thus, to preserve power (i.e., more df), 
zero-order correlations were preferred.  
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Patient and Caregiver QOL: What really matters? 
 Hypothesis 6 proposed that better functioning across domains of SR, “hot” and “cold” 
EF, and better physiological functioning would contribute to better QOL for both patients and 
caregivers.  A correlation matrix including patient and caregiver ratings of SR, EF, and QOL 
informed the contribution of SR (as rated by both patients and caregivers) to QOL (as rated by 
both patients and caregivers).  Results are shown in Table 9.  Although not an explicit 
hypothesis, the relationship between patient and caregiver QOL and relationship satisfaction 
were of interest.  Correlations revealed that these relationships were weak (QOL: r = .12, ns; 
relationship satisfaction: r = .21, ns), which is consistent with previous research. 
 First, patient perceptions of SR were moderately associated with patients’ QOL.  When 
patients perceived less rumination, more dyadic cohesion, and less social anxiety, they rated 
significantly better QOL.  Smaller, non-significant correlations revealed a similar pattern for 
emotional lability and global regulation, such that better functioning was related to better 
QOL.  While better “cool” EF appeared to positively relate to QOL, better “hot” EF was 
related to worse QOL for patients.  With regard to physiological functioning, lower levels of 
A1c (i.e., better metabolic functioning) and higher HRV (i.e., better autonomic functioning) 
were related to better QOL as rated by patients, although these correlations did not reach 
significance.  In sum, Hypothesis 6 was generally supported with regard to patient QOL, as 
better SR, better “cool” EF, and better physiological functioning were associated with better 
QOL. 
 Not surprisingly, patient perceptions of SR were not as strongly or consistently related 
to caregivers’ ratings of QOL.  Correlations between patients’ ratings of SR and EF and 
caregiver rated QOL were generally weak and non-significant.  This idiosyncratic pattern of 
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results indicates that patient reports of SR, as well as their EF and physiological functioning, 
are less important to caregiver QOL, which does not support Hypothesis 6. 
 Given that patient ratings of SR were more closely related to patient rated QOL, a 
similar pattern was expected to emerge for caregiver ratings of patients’ SR and caregiver 
rated QOL, given shared rater variance.  Although caregivers’ QOL was not significantly 
influenced by their perceptions of patients’ self-regulatory functioning in any domain, as 
reflected by weak to moderate, non-significant correlations, caregiver ratings of SR were 
generally correlated with their QOL more strongly than patient ratings of SR, when comparing 
domains (except dyadic cohesion). Caregiver perceptions of patient SR were less important to 
patient rated QOL, as reflected in generally weak, non-significant correlations.  In sum, ratings 
of SR, EF, and physiological functions appeared to be most convergent when the rater was the 
same (i.e., when patients’ SR ratings were correlated with patient QOL, when caregiver SR 
ratings were correlated with caregiver QOL). 
 Given the lack of strong and significant correlations between ratings of SR and QOL, 
even when rated by the same individual, a series of hierarchical regressions was conducted to 
examine other factors that might contribute to QOL ratings, above and beyond an individual’s 
perception of SR.  Although patient perceptions clearly influenced their own QOL more than 
their caregiver’s QOL, and vice versa, the contribution of the “other rater” to self-ratings 
remained unclear. That is, the incremental contribution of others’ perceptions, above and 
beyond self perceptions, to QOL were examined for both patients and caregivers.  Caregivers’ 
ratings’ of patients’ SR abilities accounted for 2% of the variance in patients’ QOL, above and 
beyond patients’ own perceptions.  On the other hand, when predicting caregiver QOL, 
patients’ perceptions of their self-regulatory abilities accounted for an additional 7% of the 
variance in caregiver QOL, above and beyond caregivers’ own perceptions of patients’ 
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functioning.  In sum, patients’ perceptions of their SR abilities appeared to contribute more to 
caregiver QOL than caregivers’ perceptions contributed to patients’ QOL. 
 The last component of Hypothesis 6 involved relationship satisfaction, as rated by both 
patients and caregivers.  Specifically, better SR, EF, and physiological functioning were 
expected to correlate with more satisfaction, as rated by both patients and caregivers.  A 
correlation matrix (see Table 4) revealed a similar pattern of generally weak to moderate 
relationships, especially for patient ratings of SR, EF and physiological functions.  Patient 
ratings of SR significantly contributed to patient relationship satisfaction in a single domain, 
dyadic cohesion (r = -.38, p < .05).  The relationships among other patient ratings were 
generally in the expected direction, but were weak to moderate, and non-significant.   Patient 
ratings similarly contributed little to caregiver ratings of relationship satisfaction.  The pattern 
of relationships among patients’ SR, EF, and physiological functions was again, more 
idiosyncratic.  While there was a significant correlation between patients’ “hot” EF and 
caregiver relationship satisfaction, it was opposite the expected direction, with better “hot” EF 
corresponding to worse relationship satisfaction for caregivers.  While patient ratings of SR 
were generally weakly and inconsistently related to relationship, caregiver ratings reflected a 
different pattern. 
 In general, caregiver ratings of patient SR were moderately and consistently related to 
relationship satisfaction, for both patients and caregivers. That is, when caregivers perceived 
patients to have more SR, both patients and caregivers rated higher relationship satisfaction.  
Although only one correlation reached significance (dyadic cohesion/caregiver relationship 
satisfaction, r = -.59, p < .01), caregivers’ ratings of patient SR across domains converged, 
supporting the idea that caregivers hold a more global view of deficits compared to patients.  
This global view, whether pertaining to self-regulatory strength or deficit, appears to 
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contribute to relationship quality for both patients and caregivers.  In general, these results 
partially supported Hypothesis 6, that better SR would correspond to better relationship 
satisfaction. This was most true when caregivers rated patients SR. 
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Table 3.1 
Distribution Statistics of Variables of Interest  
        Skewness Statistic (SE=.388) 
Measure  Patient   Caregiver 
WCST   1.038   - 
IGT   -.364   - 
JLO   -.322   - 
SPM   -.534   -  
A1c   -.707   - 
MSSD   2.943a, .335b  - 
BRIEF A  .388   .701 
CNSLS  .927   .212 
RS   -.645   -.173 
BFNE   .528   .509 
RDAS   .638   .377 
ALS-FRS  -.128   - 
QOL   -.857   -.329   
Note. WCST = Wisconsin Card Sorting Test; IGT = Iowa Gambling Test; JLO = Judgment of 
Line Orientation Test; SPM= Standard Progressive Matrices; A1c = glycosolated hemoglobin; 
MSSD = heart rate variability; BRIEF-A = Behavior Rating of Executive Functions-Adult 
version; CNSLS = Center for Neurologic Study- Lability Scale; RS = Rumination Scale; 
BFNE = Brief Fear of Negative Evaluation Scale; RDAS = Revised Dyadic Adjustment Scale; 
ALS-FRS= Amyotrophic Lateral Sclerosis Functional Rating Scale; QOL= Quality of Life 
 aSkewness statistic prior to transformation; bSkewness statistic following transformation. 
 
Table 3.2 
Inter-correlations Among Patient and Caregiver Reports of Patients’ Self-Regulatory Capacity 
Caregiver Ratings      Patient Ratings         
                     Global 
Variable  M (SD) Emotional Lability Rumination Lack of Cohesion Social Anxiety Dysregulation  
4.21 (5.45)  -15.09 (4.36) 8.02 (4.23)  28.63 (11.81)  95.89 (17.94) 
Emotional Lability 12.89 (4.47) .581**   -.031  -.032   .152   .196 
Rumination  -15.33 (4.10) -.136   .148  .001   -.139   .299 
Lack of Cohesion 6.19 (3.41) .232   -.068  .192   .159   .045 
Social Anxiety 25.97 (12.12) .090   .152  -.068   .425**   .050 
Global Dysregulation 88.30 (18.62) .035   .074  -.257   .125   .312   
Note. Emotional Lability, Center for Neurologic Study- Lability Scale; Rumination, Rumination Scale; Lack of Cohesion, Revised 
Dyadic Adjustment Scale; Social anxiety, Fear of Negative Evaluation Scale; Global Dysregulation, Behavior Rating of Executive 
Functions-Adult version. 
*p < .05; **p < .01. 
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Table 3.3 
Inter-correlations Among Patients’ Ratings of Self-Regulation Across Domains         
Variable Emotional Lability Rumination Lack of Cohesion Social Anxiety Global  Dysregulation  
Emotional Lability   1  .100   .125   .167   .325* 
Rumination      1   -.047   .597**   .456**  
Lack of Cohesion        1   .064   -.170 
Social Anxiety           1   .224 
Global Dysregulation              1   
Note.  Emotional Lability, Center for Neurologic Study- Lability Scale; Rumination, Rumination Scale; Lack of Cohesion, Revised 
Dyadic Adjustment Scale; Social anxiety, Fear of Negative Evaluation; Global Dysregulation, Behavior Rating of Executive 
Functions-Adult version. 
*p < .05; **p < .01. 
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Table 3.4 
Inter-correlations Among Caregivers’ Ratings of Self-Regulation Across Domains       
Variable Emotional Lability Rumination Lack of Cohesion Social Anxiety Global  Dysregulation  
Emotional Lability  1   .180  .395*   .353*   .440** 
Rumination      1  -.130   .347*   .513** 
Lack of Cohesion        1   .196   .146 
Social Anxiety         1   .347* 
Global Dysregulation            1    
Note.  Emotional Lability, Center for Neurologic Study- Lability Scale; Rumination, Rumination Scale; Lack of Cohesion, Revised 
Dyadic Adjustment Scale; Social anxiety, Fear of Negative Evaluation; Global Dysregulation, Behavior Rating of Executive 
Functions-Adult version. 
*p < .05; **p < .01.
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Table 3.5 
Inter-correlations Among Measures of Neuropsychological Functioning  
Measure  Poor “cool” EF Poor “hot” EF  Visuo-spatial skills Intelligence  
Poor “cool” EF 1   .246   -.196   -.416*   
Poor “hot” EF     1   -.147   -.338*   
Visuo-spatial skills       1   .573**  
Intelligence            1   
Note.  Poor “cool” EF = Wisconsin Card Sorting Test; Poor “hot” EF = Iowa Gambling Test; Visuo-spatial skills = Judgment of Line 
Orientation Test; Intelligence = Standard Progressive Matrices. 
*p < .05; **p < .01.
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Table 3.6 
Inter-correlations Among Measures of Executive Functions and Self-Regulation         
SR Domain          EF Measures                      EF Measures (IQ Partialled)  
                 Poor        Poor           Poor    Poor 
   M (SD)  “cool” EF “hot” EF Intelligence   “cool” EF “hot” EF  
Patients’ Ratings     18.68 (13.33) 10.59 (31.46) 38.51 (12.75) 
Emotional Lability 14.21 (5.45)  -.162  -.090  .116    -.126  -.054 
Rumination  -15.09 (4.36)  .082  .047  -.078    .055  .0 
Lack of Cohesion 8.02 (4.23)  .214  .151  -.064    .207  .137 
Social Anxiety 28.63 (11.81)  .089  .016  .346*    .273  .151 
Global Dysregulation 95.89 (17.95)  -.057  -.090  -.081    -.100  -.125 
Caregivers’ Ratings  
Emotional Lability 12.89 (4.47)  -.070  -.066  .188    .009  -.003 
Rumination  -15.33 (4.10)  .354*  .045  -.407*    .222  -.108 
Lack of Cohesion 6.19 (3.41)  -.155  -.212  .467**    .049  -.065 
Social Anxiety 25.67 (12.12)  .137  .039  -.003    .150  .041 
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Global Dysregulation 88.30 (18.62)  .095  .006  -.160    .032  -.052 
Note. Emotional Lability, Center for Neurologic Study- Lability Scale; Rumination, Rumination Scale; Lack of Cohesion, Revised 
Dyadic Adjustment Scale; Social anxiety, Fear of Negative Evaluation Scale; Global Dysregulation, Behavior Rating of Executive 
Functions-Adult version; Poor “cool” EF = Wisconsin Card Sorting Test; Poor “hot” EF = Iowa Gambling Test; Intelligence = 
Standard Progressive Matrices. 
*p < .05; **p < .01.
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Table 3.7 
Inter-correlations Among Patients’ Physiological Functions and Self-Regulation 
                Patients’ Functioning      
Self-Regulation Measure  HRV  A1C      
Patient Ratings 
 M (SD)   1.51 (.42) 5.38 (.45) 
 Emotional Lability  -.344*  .054 
 Rumination   -.193  .258  
 Lack of Cohesion  .072  .000 
 Social Anxiety  -.195  .134 
 Global Dysregulation  -.190  .427** 
 Poor “cool” EF  .342*  .010 
 Poor “hot” EF   .199  .105 
Caregiver Ratings 
 Emotional Lability  -.258  .150 
 Rumination   .261  .243 
 Lack of Cohesion  -.174  .205 
 Social Anxiety  -.140  .285 
 Global Dysregulation  -.077  .328*      
Note. Caregivers did not complete the WCST and IGT tasks; Emotional Lability, Center 
for Neurologic Study- Lability Scale; Rumination, Rumination Scale; Lack of Cohesion, 
Revised Dyadic Adjustment Scale; Social anxiety, Fear of Negative Evaluation Scale; 
Global Dysregulation, Behavior Rating of Executive Functions-Adult version; Poor 
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“cool” EF = Wisconsin Card Sorting Test; Poor “hot” EF = Iowa Gambling Test; 
Intelligence = Standard Progressive Matrices. 
*p<.05; **p<.01 
 
Table 3.8 
Inter-correlations Among Self-Regulation, Quality of Life, and Relationship Satisfaction       
   Measure         QOL         Relationship Satisfaction    
      Patient  Caregiver   Patient   Caregiver   
M (SD)     66.03 (15.99) 7.49 (1.46)   86.39 (16.02)  90.36 (12.40) 
Patients’ Ratings  
Emotional Lability   -.161  .110    -.224   .094 
Rumination    -.349*   .005    -.023   -.013 
 Lack of Cohesion   -.403*  -.284    -.377*   -.083 
Social Anxiety   -.500** -.111    -.204   -.046 
Global Dysregulation   -.200  -.057    .069   -.213 
Poor “cool” EF   -.193  .117    -.205   .068 
Poor “hot” EF    .276  .251    -.216   .346* 
HRV     .078  .042    .022   .195 
A1c     -.154  .314    -.086   -.103 
Caregivers’ Ratings      
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Emotional Lability   -.159  -.221    -.225   -.181 
Rumination    .018  -.281    -.205   -.029 
Lack of Cohesion   -.214  .110    -.265   -.593** 
Social Anxiety   -.140  -.114    -.306   -.289 
 Global Dysregulation   .151  -.131    -.250   -.174   
*p<.05; **p<.01
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Figure3.1 
Quadratic Relationship Between Patient and Caregiver Cohesion Ratings. 
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Figure 3.2 
 Interaction of “Hot” and “Cool” EF in Predicting Patient Cohesion. 
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Figure 3.3 
 Interaction of “Hot” and “Cool” EF in Predicting Caregiver Cohesion. 
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Chapter Four 
Discussion 
 ALS is increasingly viewed as a multi-system disorder accompanied by cognitive and 
behavioral changes (Strong, 2001, 2008; Strong & Rosenfeld, 2003).  However, an extensive 
body of research has failed to clarify the nature or prevalence of these extra-motor symptoms 
in ALS.  The current study aimed to elucidate the prevalence and pattern of executive deficits 
and behavioral dysregulation in patients with ALS.  
Does the Pattern of Self-Regulatory Deficits in ALS Reflect a “Distinct” Disorder?  
 This research revealed that the scope of extra-motor impairment in ALS can be wide, 
with deficits existing on a continuum such that some, but not all, patients evidence deficits in 
self-regulatory abilities to effectively manage social relationships, emotions, and thought 
processes.  This informs research and clinical work with MND as self-regulatory deficits may 
be part of the disease process for some patients. 
 Of particular interest in this study was convergence of self-regulatory deficits across 
domains.  Given research that executive control and behavioral self-regulation rely on a similar 
resource, and that expenditure of this resource on one task can impair subsequent performance 
on others, it was surprising that there was not a consistent pattern that emerged among 
domains of self-regulation, “hot” and “cold” EF, and physiological regulation.  Specifically, 
deficits in EF were expected to correspond to behavioral deficits across domains of self-
regulation as well as worse physiological functioning.   Given that the IGT task, used as a 
measure of “hot” EF, is a more context-dependent measure representative of “real-world” 
situations, one might have expected to see stronger relationships among other measures of 
“applied” behavioral self-regulation (i.e., social anxiety, rumination, emotional lability, and 
global regulation).  Conversely, “cool” EF was more highly correlated with various forms of 
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behavior regulation in this sample.  Specifically, more emotional lability (patient-rated) was 
related to better “cool” EF (albeit not significantly), which is inconsistent with previous 
research that emotional lability relates to worse “cool” EF (McCullagh et al., 1999). On the 
other hand, “hot” EF was more highly correlated with patient and caregiver ratings of QOL 
and relationship satisfaction. It is possible that “cool” EF most strongly relates to measures 
assessing how people behave or act (emotional lability, dyadic cohesion) and “hot” EF relates 
more closely to measure of how people feel (social anxiety, quality of life). Given the related, 
yet distinct nature of the “hot” and “cool” components of EF, conceptualizing EF as a non-
unitary construct is informative and important, especially for future studies.  This may be 
particularly true in ALS as deficits may influence important clinically important outcomes.  
Who is Most Accurate in Rating Patient Behavior? 
 Even more, the pattern of inter-correlations among domains of SR differed depending 
on who was rating patients’ self-regulatory abilities.  Despite a lack of significant mean-level 
differences between patients and caregivers, a clear tendency emerged for caregivers to rate 
patients’ deficits more globally, such that caregiver ratings of patients’ self-regulatory abilities 
aligned across domains (i.e., higher inter-correlations). Thus, caregiver ratings were indicative 
of a more pervasive pattern of decline in self-regulatory capacity compared to patients.  
Perhaps, it is caregivers who bear the burden of patients’ inability to regulate, therefore 
resulting in more general or “accurate” ratings.  Likewise, the impact of these deficits may be 
more global for caregivers than patients.  On the other hand, it is possible that caregivers are 
most psychologically vulnerable to patients’ physical decline (compared to patients), and that 
caregiver ratings reflect their own internal experience rather than the patients’ true abilities.  
For example, caregivers of patients with ALS appear to suffer emotionally (as evidenced by 
increased depression and perception of burden; Gauthier et al., 2007) and physically, as 
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patients become more incapacitated.  Thus, caregiver ratings of patients’ self-regulation could 
better reflect their own quality of life, which has been shown to decline as ALS progresses. 
Thus, the use of behaviorally specific measures may be most useful, especially when relying 
on caregiver reports.   
 In general, patients appeared to perceive more variability (i.e., lower inter-correlations) 
among self-regulatory abilities, such that self-regulatory deficits in one domain were not 
suggestive of deficits across other domains.  This discrepancy across domains (i.e., social, 
thought process, emotions, cognitive) could be attributed to inaccurate perceptions of their 
condition.  Alternatively, patients could be more flexible and realistic than caregivers in 
evaluating the specific deficits they experience.  From a methodological standpoint, a lack of 
strong or significant correlations could be an artifact of the measures used.  Although the 
scales used in this study generally had acceptable internal consistency, the construct validity of 
these measures as measures of self-regulation is not fully established.  Interestingly, the 
measure that was most strongly and consistently related to other measures for both raters was 
the BRIEF-A, which was designed as a measure of global regulation of behavior across a 
variety of areas. It is possible that this measure best captures the variety of ways in which self-
regulatory deficits are manifest.  On the other hand, this measure did not highly correlate with 
measures of “cool” or “hot” EF.  Thus, the idea that EF and SR draw upon a common resource 
but make unique contributions to behavior (Kaplan & Berman, 2010) is supported. 
 Taken together, there were few mean-level differences between patient and caregiver 
ratings, but there was a clear difference in the pattern of inter-correlations between raters 
across measures.  Patient and caregiver agreement was highest when they rated the same 
individual (i.e., the patient) and more overt/observable behavior (e.g., emotional lability), and 
less when they expressed their own experience or rated the patients’ internal experience (e.g., 
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rumination).  Of particular interest was the disagreement between patients and caregivers in 
perceptions of relationship cohesion.  Given the tendency of caregivers to interpret patients’ 
deficits as part of a pervasive pattern, and their susceptibility to decreased QOL, caregivers 
were expected to perceive less cohesion in their relationship. However, patients tended to 
perceive less cohesion.  Patient-caregiver agreement was highest at the polar ends of the 
spectrum (at lower scores and at higher scores).  Even more, the effect of good “cool” EF 
differed for patients and caregivers.  For patients, good “cool” EF was associated with more 
cohesion, only if there was also good “hot” EF.  For caregivers, however, the relationship 
between good “cool” EF and cohesion was strengthened by poor “hot” EF.  Thus, the spectrum 
of impairment appears to vary both quantitatively (how much impairment) and qualitatively 
(what kind of impairment).  Eliciting patient and caregiver reports may provide unique insights 
into the nature of the deficits as well as the psychological experience of the patient-caregiver 
dyads. 
Is Self-Regulation Important for QOL? 
 A plethora of research has recently focused on QOL in ALS patients and their 
caregivers.  Consequently, the current research aimed to examine patient-caregiver agreement 
regarding patients’ self-regulatory capacity, and the contribution of these perceptions on 
quality of life.  Previous literature consistently suggests that caregivers may be more 
“vulnerable” to the progression of ALS, generally rating poorer QOL over the course of the 
illness (Averill et al., 2007; Roach et al., 2009).  However, caregiver QOL did not appear to be 
influenced by caregiver perceptions of patients’ self-regulatory abilities.  It is possible that the 
more global factors (e.g., progression of time and disease) are most important to caregiver 
QOL.  Conversely, several domains of self-regulation were related to patient QOL.  
Rumination, lack of cohesion, and social anxiety were linked to worse QOL for patients.  
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Despite this evidence for the link between SR and QOL, research consistently suggests that 
patients generally maintain QOL over the course of their illness (Robbins, Simmons, Bremer, 
Walsh, & Fischer, 2001).  In sum, although SR may be an important component of patients’ 
QOL, there are likely other important factors contributing to or preserving well-being in ALS 
patients.   Future research is needed to inform 1) the factors that contribute to declines in 
caregiver well-being and 2) the “protective” factors regarding patient well-being, and enhance 
interventions with ALS caregivers. 
Are Physiological Resources Important? 
 This study lends support to the claim that glucose is an important component of 
successful self-regulation (Benton et al., 1994; Gailliot, 2008; Gailliot & Baumeister, 2008; 
Fairclough & Houston, 2004).  Glycosolated hemoglobin (i.e., A1c) was significantly related 
to patient and caregiver perceptions of global regulation.  Thus, patients with better regulated 
glucose were viewed and viewed themselves as more regulated on a global measure of self-
regulation.  Although non-significant, the general pattern that emerged was consistent with 
expectations across domains, such that lower (e.g., better) A1c values were associated with 
less emotional lability, less rumination, less social anxiety, and better “cool” and “hot” EF for 
both patients and caregivers.  Thus, although a causal mechanism is not established, it is 
possible that measures reflective of glucose (tolerance or regulation) could serve to “mark” 
those patients who are also likely to experience self-regulatory deficits.   
 However, the current study only partially converges with research linking vagally-
mediated HRV to prefrontal activity and SR (Brosschot et al., 2006; Thayer, 2007; Thayer, 
Hansen, Saus-Rose, & Johnsen, 2009; Segerstrom & Solberg Nes, 2007).  Higher resting HRV 
was associated with less emotional lability according to patients (but not caregivers), which 
converges with research linking emotional arousal to decreased (i.e., worse) HRV (Thayer et 
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al., 2009).  Similarly, patient and caregiver ratings of patients’ self-regulatory abilities across 
other domains were consistently in the expected direction (albeit non-significant) with better 
regulation linked to higher HRV.  However, the pattern of associations among measures of EF 
and HRV were unexpected, such that better “cool” EF was significantly associated with lower 
(e.g., worse) baseline HRV in the current sample. A similar, non-significant pattern emerged 
between “hot” EF and HRV.  Taken together, this study suggests the mechanisms by which 
HRV indexes the capacity for self-regulation in ALS patients may differ from other “healthy” 
samples.  If decreased HRV is in fact associated with the disease process of ALS (Oey et al., 
2002; Pisano et al., 1995), examining individual differences in HRV may be particularly 
informative to self-regulatory processes.  Alternatively, HRV could more dynamic in ALS 
patients than in “healthy” samples (Sinnreich, Kark, Friedlander, Sapoznikov, & Luria, 1998), 
which may suggest both theoretical and methodological adaptations for non-healthy samples. 
Limitations 
 There are several limitations to the current research that should be acknowledged when 
interpreting results and drawing conclusions.  First, the sample of patients was both small and 
varied.  Although there was sufficient power to detect large effects, which had been previously 
obtained in research on SR and EF, a larger sample would have increased the power to detect 
small to moderate effects, which may be clinically important in ALS.  Even more, a small 
sample size necessitated careful selection of control variables to preserve degrees of freedom 
in analyses (Breaugh, 2006; Lynam, Hoyle, & Newman, 2006; Segerstrom, 2009).  A related 
methodological concern is Type 1 error due to multiple comparisons.  The current study did 
not involve a correction (e.g., Bonferroni) for Type 1 error.  Given the limited sample size, the 
caution in relying on p-values in small samples, the risk of neglecting Type 2 error, and the 
absence of theoretically guided a priori hypotheses (in many instances), preservation of power 
66 
 
was a priority.  The sample was also heterogeneous with regard to the site of MND and disease 
onset.  ALS and PLS patients were included in the sample given the similar conceptualizations 
of the disorders as MND.  Despite the relationship between ALS and PLS, they clearly have 
different disease trajectories, with PLS progressing slower and being less fatal.  Thus, it was 
important to identify any disease-related differences the groups with regard to demographics or 
variables of interest.  This did not appear to influence the results of the current study, but there 
are likely differences with regard to treatment implications and survival.  Methodological 
limitations should also be considered.  To accommodate patients of varying functional levels, 
measures that could be administered independent of speech and mobility were selected. 
Therefore, the selection of measures was largely influenced by practical considerations with 
this population, which is a common concern in the assessment of individuals with ALS.  Thus, 
it is possible that more valid or reliable measures (e.g., intelligence) would enhance confidence 
in the current results. However, given the similar patterns of inter-correlations among 
measures, it is unlikely that the substitution of any specific measure would substantially alter 
the conclusions of this research.  However, the need to establish and validate appropriate 
assessment techniques for samples such as ALS patients (e.g., with limited mobility or 
communicative abilities) is important.   
 Overall, ALS patients appear to be prone to a variety of self-regulatory deficits, 
ranging from subtle to severe.  However, this research suggests that both the quantity and 
quality of impairment varies, and that the correlates of these deficits may be different for 
patients and caregivers. However, adequate self-regulation across domains appears to 
influence quality of life for patients and caregivers. 
 
Copyright © Abbey R. Roach, 2010 
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